Sarcoma  >>  Calsed (amrubicin)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Calsed (amrubicin) / Sumitomo Pharma, BMS
ARSARC-PI-0010, NCT01259375: Amrubicin Chemotherapy as First Line in Metastatic or Unresectable Soft Tissue Sarcoma

Completed
2
24
US
Amrubicin
University of Utah
Soft Tissue Sarcoma
02/16
02/16

Download Options